Responsability

There are many ways to go about exploratory and preclinical research and although the stringent standards of the pharmaceutical industry are demanding, we apply them. Experimental data that is not robust or significant should not be considered as validated. Yet this does not mean we overlook partially conclusive data. Indeed, we believe that the breaches opened when experiments deliver astonishing results can be the paths reach new levels.

Project management, planning and anticipation are the keys to drive ambitious projects forward towards success. Although we do stand-alone medicinal chemistry and biological profiling studies, we tend to ensure our managers have the necessary insight into the entire research process so that the experiments carried-out under their supervision are designed to fit into research program’s context. When our partners have not done this planning appropriately to our standards, we help them look further ahead as we believe it is our responsibility as a partner.
 

Project confidentiality is of paramount importance to us. Our partners choose us knowing that their project is safe with METABRAIN. The electronic notebook (ELN) used enable a rigorous data management, backup and security.

Metabrain Research understands its biotech and pharma partners need to maintain an exclusive right to exploit their IP. When we collaborate at precompetitive stages, before IP generated, we ensure with all the stakeholders that we share a clear vision of how the inventions generated will be developed and ultimately exploited.
 

We make sure that we have open, honest and timely communication with partners concerning research programmes and studies. Our secured electronic data rooms permit our partners to stay in touch with the data generated on a daily basis. We thus try to avoid any tensions by communicating in an extensive way, and we strive to do this internally as well.

Metabrain research is an environmentally responsible company doing its best to limits its use of toxic and polluting reagents and maximise recycling. For example, we are investing in Prep-SFC technologies for our chemical purification processes, which will reduce our solvents consummation by at least 10-fold (and up to 100-fold for some compounds) compared to standard prep-HPLC methods. We are planning to obtain an ISO9001 certification for our management processes, which includes environmental issues, in 2011.

Corporate social responsibility at Metabrain is another important aspect of our quality as we strive to retain our staff through a series of welfare measures, such as family-wide health insurance coverage and participation to financial benefits. We also do our best to avoid stay in touch with the local community, by communicating heavily about what we do in the local press.